Advertisement

Topics

Ansun BioPharma Adds Stanley Lewis to C-Suite

12:41 EDT 12 Oct 2018 | Xconomy

Ansun BioPharma has appointed Stanley Lewis to serve as its chief medical officer. Lewis comes to Ansun from TaiMed Biologics, where as CMO he oversaw the development of a treatment for multi-drug resistant HIV through to FDA approval. San Diego-based Ansun said Lewis will oversee the late-stage development of its lead candidate, DAS181, a treatment […]

Original Article: Ansun BioPharma Adds Stanley Lewis to C-Suite

NEXT ARTICLE

More From BioPortfolio on "Ansun BioPharma Adds Stanley Lewis to C-Suite"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...